Market
Highlights
The
people with diabetes and rheumatoid arthritis are more likely to suffer from
patellar tendinitis. The patient population suffering from diabetes and
rheumatoid arthritis is increasing continuously, which significantly increased
the demand for the treatment of the tendinitis drugs. Additionally, adoption of
the sedentary lifestyle has fuelled the market growth.
Over
the last decade, the total number of hospitals has increased to a great extent,
which has influenced the growth of the market positively. Moreover, increasing
demand for better treatment and changing reimbursement policies have fueled the
market growth.
The
global patellar tendinitis market is expected to grow at a CAGR of ~8.1% during
the forecast period 2017-2023.
Regional
Analysis
The
Americas patellar tendinitis market is expected to show an extensive growth
owing to increasing number of sports injuries, availability of cost-effective
treatment, and flourishing growth of the sports medicine. Furthermore,
technological advancement in the health care also accelerates the market
growth.
Europe
holds the second largest share of the global market. As per the European Union
Injury Database, home, leisure, and sports injuries accounted for 73% of all
injuries treated every year. It is also stated that sports injuries were common
among the population from 10 to 19 years of age. Furthermore, over 7.9 million
children under the age of 15 are treated for an injury in European Union (EU)
hospitals each year. Out of the total sports injuries, team ball sports account
for 40% of all hospital-treated injuries, and the prevalence of sports injuries
was found to be higher among men than women. Additionally, In the EU, muscle
strains, tendonitis, and stress fracture are the common chronic sports
injuries. As per the article published in the Clinics in the Orthopedic
Surgery, traumatic tendon injuries are commonly treated sports injuries,
especially in the emergency department of the hospital. Additionally, soccer,
tennis, indoor ball games, and downhill skiing are various games resulting in
Achilles tendon ruptures.
The
Asia Pacific is the fastest growing patellar tendinitis market across the
globe. Japan holds a major share of the regional market due to the availability
of technology and huge healthcare spending. Rapidly developing the economy,
increasing healthcare expenditure, and government initiatives for research
& development will drive the market in China and India over the assessment
period.
The
Middle East and Africa hold the least share of the global market due to limited
availability of medical facilities. The UAE, Saudi Arabia, and Kuwait are
expected to drive the Middle East & African market whereas, the African
region is expected to witness a moderate growth.
Segmentation
The
global patellar tendinitis market is segmented on the basis of diagnosis,
treatment, and end user. On the basis of diagnosis, it is segmented into the
physical examination, imaging tests, and others. An imaging test is further
segmented into X-rays, Ultrasound, and Magnetic resonance imaging (MRI).
The treatment segment is divided into corticosteroid injection, platelet-rich
plasma injection, surgery, Medical devices, and others. Medical devices are
further segmented into the mechanical band, support tape, pre-cut strips,
continuous rolls, and others. Based on the end user, it is segmented into
hospitals & clinics, research laboratories, and others.
Key
Players
Some
of key the players in the market are Toshiba Medical Systems Corporation
(Japan), Carestream Health (U.S.), Nihon Kohden Corporation (Japan), Electrical
Geodesics Inc. (U.S.), Fujifilm Holdings (Japan), GE Healthcare (U.S.), Siemens
Healthcare(U.S.), Philips Healthcare (U.S.), Shimadzu Corporation (Japan),
Masimo Corporation (U.S.), Hologic (U.S.), Esaote (Italy), and others.
No comments:
Post a Comment